Tuesday, 1 August 2017

Growth Potential of the Disposable Medical Device Sensors Market

Download PDF  Brochure:
http://www.marketsandmarkets.com/pdfdownload.asp?id=1259

The Disposable Medical Device Sensors   market is poised to reach USD 5,936 Million by 2020, growing at a CAGR of 10.3% during the forecast period of 2015 to 2020.

 Market growth can be attributed to the growing prevalence of diabetes and other infectious diseases across the globe, government support for research and development activities in medical sensors, various benefits such as faster analysis, low costs, ease of use, and rising needs to curtail escalating healthcare costs
                                                    

Key players :
Some of the major players in this market include Medtronic plc. (Ireland), GE Healthcare (U.K.), Philips N.V. (Netherlands), Smiths Medical (U.K.), TE Connectivity (Switzerland), Freescale Semiconductors, Inc. (U.S.), Omnivision Technologies, Inc. (U.S.), STMicroelectronics (Switzerland), Analog Devices, Inc. (U.S.), and Honeywell International, Inc. (U.S.).

Geography:
The market is divided into North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa, which is further analyzed at country levels.. In addition, increasing investments in the healthcare industry by key market players, rising demand for advanced healthcare technologies, and expansion of private sector hospitals to rural areas in countries such as China, Taiwan, and India are driving the growth of this region.

Download Sample Report :
http://www.marketsandmarkets.com/requestsample.asp?id=1259

 The Disposable Medical Device Sensors   market is segmented into patient monitoring devices, diagnostic testing devices, imaging devices, and therapeutic devices. The diagnostic testing devices segment is further divided into HIV test kits, pregnancy test kits, drug and alcohol test kits, and blood glucose test strips. The therapeutic devices segment is further divided into insulin pump sensors, dialysis device sensors, cardiac therapy devices, and cardiac catheter sensors.

 The patient monitoring devices segment is categorized into continuous blood pressure monitors, pulse oximeters, cardiac monitors, continuous glucose monitoring devices, implantable loop recorders, smart pills, and others. The imaging devices segment is divided into capsule endoscopes and disposable endoscopes..


DNA Markers an Important product segment for Life science research suppliers- Asia to expect rapid growth

Molecular Weight Marker Market, by Products (DNA, RNA, Protein Ladders), by Type (Prestained, Specialty), by Application (PCR, Western Blotting, Gel Extraction), by End User (Academic Institutes, Pharmaceutical Companies, CRO) – Global Forecast to 2019
Molecular weight markers are extensively used in almost all areas of life science applications. Due to this, the adoption rate for these products is very high and is expected to increase in future.

Molecular weight markers market is a research-driven market. R&D expenditure is important indicators for this market. North America accounted for 37.74% of the global R&D spending in 2010. The U.S. alone accounted for 35.33% of all R&D spending in the world. According to estimates from the World Bank, the R&D spending in North America increased at a CAGR of 4.56% between 2001 and 2010. On the other hand, R&D spending in Asia increased from $158.94 billion in 2001 to $329.31 billion in 2010, at a CAGR of 8.43%. China has the highest growth rate for R&D spending between 2001 and 2010.


The government in China is also undertaking various initiatives to promote genomics research. For instance, it is planning to invest more than $300 billion in biotechnology between 2012 and 2017. High focus on biotechnology research is another major factor driving the growth of the molecular weight markers market in Asia. Asia is growing faster in past few years and is expected to grow at the fastest rate in forecasted period. Emerging Asian countries such India, China and Japan are expected to have healthy growth in the coming five years, considering the huge R&D spending as well as growing technical know-how to increasing public funding.

The molecular weight markers in Asia expected to grow at the highest CAGR in the forecast period (2014–2019). Asian countries are expected to witness a steady year-on-year growth, due to increase in demand for innovations in proteomics and genomic research. Moreover, an increase in healthcare budgets and R&D activities in this region will further fuel the demand for molecular weight markers in this region.

The DNA is estimated to have the largest share of the molecular weight markers market in 2014. The market is expected to be driven by increased research and development spending by biotechnology companies, government and public sector funding for research. In addition, new innovations have contributed to grow the market to a great extent. The use of DNA markers will be boosted by the increasing research activities in genomics and with the advent of cheaper sequencing technologies.


The Interventional Cardiology and Peripheral Vascular Devices Market is Expected to Reach USD 31.47 Billion by 2021

“Interventional Cardiology & Peripheral Vascular Devices Market (Angioplasty Balloon, Stent, Catheters, EVAR Stent Grafts, Abdominal Aortic Aneurysm, IVC Filter, Plaque Modification, Hemodynamic Flow Alteration, Accessories, Guidewire) – Forecasts to 2021”

This report provides a detailed overview of the major drivers, restraints, challenges, opportunities, current market trends, and strategies impacting the interventional cardiology and peripheral vascular devices market, along with revenue estimates & forecasts and market share analysis.
Browse through market data tables and the in-depth ToC of the Global Interventional Cardiology and Peripheral Vascular Devices Market (2016–2021)



The global interventional cardiology and peripheral vascular devices market is expected to reach USD 31.47 billion by 2021 from USD 21.83 billion in 2016, at a CAGR of 7.1% from 2016 to 2021. Rising aging population, rising incidence of cardiovascular diseases, increasing demand of minimally invasive procedures, and technological advancements are the major factors driving the growth of this market.

On the basis of product, the interventional cardiology and peripheral vascular devices market is segmented into angioplasty balloons, angioplasty stents, catheters, EVAR stent grafts, IVC filters, plaque modification devices, hemodynamic flow alteration devices, and accessories. In 2016, the angioplasty stents segment is expected to account for the largest share of the market. High growth in this segment can be attributed to rising number of regulatory approvals, technological advancements, and increasing initiatives by companies for new product launches.

Get The PDF Brochure For This Report@

On the basis of type, the angioplasty stent market is segmented into drug-eluting stents, bare-metal stents, and bioabsorbable stents. In 2016, the drug-eluting stents segment is expected to account for the largest share primarily due to the increasing number of regulatory approvals and technological advancements.

On the basis of type, the catheters market is segmented into IVUS/OCT, angiography catheters, and guiding catheters. In 2016, the angiography catheters segment is expected to account for the largest share of the market.

On the basis of type, the EVAR stent grafts market is segmented into abdominal aortic aneurysms and thoracic aortic aneurysms. In 2016, the abdominal aortic aneurysms segment is expected to account for the largest share primarily due to the rising incidence of smoking and hypertension.

On the basis of region, the global interventional cardiology and peripheral vascular devices market is segmented into North America, Europe, Asia, and the Rest of the World (RoW). Asia is expected to grow at the highest CAGR during the forecast period. Growth in this regional segment is driven by factors such as the rising prevalence of cardiovascular diseases, increasing number of conferences & symposia, and increasing focus of major players on the Asian market.
Some of the major players operating in the interventional cardiology and peripheral vascular devices market are Abbott Laboratories (U.S.), Boston Scientific Corporation (U.S.), B. Braun Melsungen AG (Germany), Cordis Corporation (U.S.), C.R. Bard, Inc. (U.S.), Medtronic plc (U.S.), and Terumo Corporation (Japan).



Friday, 28 July 2017

Pharmacovigilance Software Market worth $154.1 Million by 2019

The report Pharmacovigilance and Drug Safety Software Market by Functionality (Adverse Event Reporting, Fully Integrated Software), Delivery Mode (On-premise, On-demand/Cloud based (SAAS)), End-user (Pharma & Biotech Companies, CROs, BPOs) - Global Forecast to 2019” The global pharmacovigilance and drug safety software market is poised to grow at a CAGR of 6.5% during 2014-2019, and is expected to reach a value of $154.1 Million in 2019.

In this report, the global pharmacovigilance and drug safety software market has been classified into many segments on the basis of functionality, namely, adverse event reporting software, drug safety audits software, issue tracking software, and fully integrated software. The global pharmacovigilance and drug safety software market is divided into two segments on the basis of delivery mode, namely, on-premise delivery mode and on-demand/cloud based (SaaS) delivery mode.

The global pharmacovigilance and drug safety software market is also segmented on the basis of end users including pharma and biotech companies, contract research organizations (CROs), business process outsourcing (BPO) firms, and other pharmacovigilance service providers.

Factors such as rising incidence rates of adverse drug reactions (ADRs) and increasing adoption of pharmacovigilance software by outsourcing companies are driving the growth of the global pharmacovigilance and drug safety software market. In addition; government regulatory bodies (such as the U.S. FDA and EMEA) have intensified safety regulations for prior and post commercialization of drugs, which has increased pressure on the pharmaceutical and biotechnology companies to manufacture safe drugs and evaluate their results post sales.

Thus, growing complexity related to drug safety regulations is expected to drive the growth of the market during the forecast period.
Get The PDF Brochure For This Report@


Geography:
North America holds the largest share of the global pharmacovigilance and drug safety software market, followed by Europe. However, Asian and Latin American countries represent high growth markets, owing to a rise in research outsourcing by pharmaceutical giants and growing public and private investments in pharmaceutical R&D in these emerging nations.
ArisGlobal (U.S.), Ennov Solutions Inc. (U.S.), EXTEDO GmbH (U.S.), Online Business Applications, Inc. (U.S.), Oracle Corporation (U.S.), Sarjen Systems Pvt. Ltd (India), Sparta Systems, Inc. (U.S.), and United BioSource Corporation (U.S.) are some of the key players in the global pharmacovigilance and drug safety software market.

The Sample Report For This Report@
http://www.marketsandmarkets.com/requestsample.asp?id=16831714

Thursday, 27 July 2017

Orthodontic Supplies Market Forecast to 2021

The report "Orthodontic Supplies Market by Removable & Fixed Braces (Brackets (Self Ligating, Lingual, Metal, Ceramic, Aesthetic), Archwire (Nickel Titanium, Stainless Steel), Ligature (Elastomeric, Wire), Anchorage Appliances, Adhesives), Patient - Forecast to 2021” This report studies the orthodontic supplies market over the forecast period of 2016 to 2021. The market is expected to reach USD 4.71 Billion by 2021, at a CAGR of 8.0% during the forecast period.
                                           

Factors such as growing number of patients with malocclusion, jaw diseases, tooth decay/tooth loss, and jaw pain; increasing disposable income and expanding middle-class population in developing countries; increasing awareness among consumers about advanced orthodontic treatments; and technological advancements in orthodontic products are propelling the growth of the orthodontic supplies market.

On the basis of product, the global orthodontic supplies market is divided into three major categories, namely, fixed braces, removable braces, and orthodontic adhesives.
Fixed Braces category is further divided into five orthodontic products segment, namely, brackets, by type (conventional, self-ligating, and lingual); brackets, by material (metal/traditional and ceramic/aesthetic); archwires (beta titanium, nickel titanium, and stainless steel); anchorage appliances (bands & buccal tubes and miniscrews); and ligatures (elastomeric ligatures and wire ligatures). The fixed braces segment is expected to grow at the highest CAGR in the next five years, owing to the low cost (as compared to removable braces), high number of patients having malocclusions and jaw diseases coupled with increased adoption of fixed braces among adolescents.
On the basis of patients, the global orthodontic supplies market is divided into two major categories, namely, children & teenagers; and adults. The children and teenagers patient segment is expected to command the largest share of the global orthodontic supplies market in 2016. This large market share can be attributed to the huge number of patients with malocclusions and jaw disorders in the patient category and increased adoption of fixed braces among adolescent children and teenagers.

The Sample Report For This Report@

High prevalence of malocclusion and jaw disorders; growing efforts to increase awareness of advanced orthodontic treatments; growing focus of global orthodontic/dental companies on emerging APAC countries; and increasing disposable income in the t region are the key factors propelling the demand for orthodontic supplies products in emerging nations. In order to leverage the high growth opportunities in these emerging nations, leading market players are expanding their presence in these countries.

Get The PDF Brochure For This Report@

North America is expected to be the largest regional segment in the global orthodontic supplies market in 2016, followed by Europe. However, the Asia-Pacific market is expected to grow at the highest CAGR from 2016 to 2021. Factors such as huge patient population with malocclusion and jaw disorders; growing efforts to increase awareness of advanced orthodontic treatments; growing focus of global orthodontic/dental companies on emerging APAC countries; and increasing disposable income coupled with growing middle class population in the APAC region are stimulating the growth of the orthodontic supplies market in the Asia-Pacific region.

3M Company (U.S.), Align Technology Inc. (U.S.), Danaher Corporation (U.S.), Henry Schein, Inc. (U.S.), DENTSPLY International, Inc. (U.S.), American Orthodontics (U.S.), Rocky Mountain Orthodontics, Inc. (U.S.), G&H Orthodontics, Inc. (U.S.), Dentaurum GmbH & Co. KG (Germany), and TP Orthodontics, Inc. (U.S.) are some of the key players operating in the global orthodontic supplies market.




Interventional Cardiology and Peripheral Vascular Devices Market Forecasts to 2021

The report "Interventional Cardiology & Peripheral Vascular Devices Market (Angioplasty Balloon, Stent, Catheters, EVAR Stent Grafts, Abdominal Aortic Aneurysm, IVC Filter, Plaque Modification, Hemodynamic Flow Alteration, Accessories, Guidewire) - Forecasts to 2021", The global interventional cardiology and peripheral vascular devices market is expected to reach USD 31.47 Billion by 2021 from USD 21.83 Billion in 2016, at a CAGR of 7.1% from 2016 to 2021. 

Rising aging population, rising incidence of cardiovascular diseases, increasing demand of minimally invasive procedures, and technological advancements are the major factors driving the growth of this market.

On the basis of product, the interventional cardiology market is segmented into angioplasty balloons, angioplasty stents, catheters, EVAR stent grafts, IVC filters, plaque modification devices, hemodynamic flow alteration devices, and accessories. The angioplasty stents segment showcase high growth potential owing to technological advancements, rising number of regulatory approvals, and increasing investments by companies to develop new devices.

On the basis of type, the angioplasty stents market is segmented into drug-eluting stents, bare-metal stents, and bioabsorbable stents. The drug-eluting stents segment is projected to witness the highest growth in this market due to increasing number of regulatory approvals and new product launches.

On the basis of type, the catheters market is segmented into IVUS/OCT, angiography catheters, and guiding catheters. The IVUS/OCT segment is projected to witness the highest growth in this market due to increasing penetration rates and rapid advancements & innovations in these systems.

On the basis of type, the EVAR stent grafts market is segmented into abdominal aortic aneurysms and thoracic aortic aneurysms. The abdominal aortic aneurysms segment is projected to witness the highest growth in this market due to rising incidence of smoking and hypertension.

The Sample Report For This Report@

Geographically, the interventional cardiology market is dominated by North America, followed by Europe, Asia, and the Rest of the World (RoW). Growth in the North American region is primarily driven by the rising incidence of cardiovascular diseases, rapidly growing geriatric population, and technological advancements. However, the Asian market is projected to grow at the highest CAGR during the forecast period.

Key players operating in the interventional cardiology market include Abbott Laboratories (U.S.), Boston Scientific Corporation (U.S.), B. Braun Melsungen AG (Germany), Cordis Corporation (U.S.), C.R. Bard, Inc. (U.S.), Medtronic plc (U.S.), and Terumo Corporation (Japan)

Get The PDF Brochure For This Report@


Wednesday, 26 July 2017

Environmental Monitoring Market

The report "Environmental Monitoring Market by Product (Monitor (Fixed, Portable), Sensor (Analog, Digital), and Software), Sampling Method (Intermittent, Continuous, Active, Passive), Application (Particulate Matter, Air, Gas, Water, Soil, Noise) - Forecast to 2021", This report studies the environmental monitoring market over the forecast period of 2016 to 2021. The market is expected to reach USD 19.56 Billion by 2021, growing at a CAGR of 7.7% during the forecast period.
Browse 75 market data tables and 42 figures spread through 172 pages and in-depth TOC on “Environmental Monitoring Market”

http://www.marketsandmarkets.com/Market-Reports/environmental-monitoring-market-216846315.html                                      
Early buyers will receive 10% customization on This report.
Increasing government initiatives to control environmental pollution levels, increasing government funding for pollution control and monitoring, ongoing installations of environment monitoring stations, and growing initiatives for the development of environment-friendly industries are some key factors driving the growth of the global market. Furthermore, emerging markets such as Japan, China, and India offer new growth opportunities for market players. However, factors such as high product costs associated with environment monitoring solutions, slow implementation of pollution control reforms, and high export barriers on environmental technologies across emerging countries are restraining the market growth.
On the basis of product, the global environmental monitoring market is divided into three major categories, namely, environmental monitors, environmental sensors, and environmental monitoring software. Environmental monitors are further categorized into fixed monitors and portable monitors. The environmental sensors segment is further divided on the basis of product architecture (analog sensors and digital sensors) and on basis of applications (temperature sensing, moisture detection, chemical detection, biological detection, particulate detection, and noise measurement).
On the basis of sampling methods, the global environmental monitoring market is divided into four major categories, namely, intermittent monitoring, continuous monitoring, passive monitoring and active monitoring. The continuous monitoring segment is expected to command the largest share of the global environmental monitoring market in 2016.
The environment monitoring market is offering high growth opportunities to the market players. Rapid industrialization and urbanization has contributed significantly towards the deterioration of air, water, and soil quality levels over the decades. With several governments playing an active role in funding and initiating effective pollution control and monitoring programs, the global environmental monitoring market is expected to grow at a significant pace in the next five years.
The Sample Report For This Report@
North America is expected to be the largest regional segment in the global environmental monitoring market in 2016, followed by Europe. However, the Asia-Pacific market is expected to grow at the highest CAGR from 2016 to 2021. Factors such as rapid industrialization in Asia-Pacific countries (such as China and India), implementation of increasingly stringent environmental regulation policies, and the growing need to comply with various environmental safety regulations are stimulating the growth of the environmental monitoring market in the Asia-Pacific region.
As of 2015, Agilent Technologies, Inc. (U.S.), Danaher Corporation (U.S.), Honeywell International Inc. (U.S.), Siemens AG (Germany), Thermo Fisher Scientific Inc. (U.S.), TE Connectivity Ltd. (Switzerland), General Electric Company (U.S.), Emerson Electric Co. (U.S.), Teledyne Technologies Inc. (U.S.), and Merck KGaA (Germany) are some of the key players operating in the global environmental monitoring market.
 Get The PDF Brochure For This Report@